Companies / IMC

IMMURON LIMITED

ASX:IMCPharmaceuticals, Biotechnology & Life Sciences
325.5M shares on issueAppendix 2A · as of 16 Dec 2025$0.038price · delayed$12.3Mmarket cap · indicative
C
Dilution grade

Share count grew 43% in 24 months; 10 cash raises in 24 months

Cash runwayno data — not a quarterly (4C/5B) cash filer
Share-count growth (24m)42.8%
Raise cadence (24m)10 cash raises
Options & rights overhang4.6% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

IMMURON LIMITED's ordinary share count increased 42.8% between March 2024 and December 2025, standing at 326M shares as of December 2025. The company raised capital 10 times in the 24-month window for total disclosed proceeds of A$7.4M, most recently raising A$3.6M in December 2025. Options and rights on issue could convert into 15M new shares, equal to 4.6% of the current share count, with 0% currently in the money. The company does not have a current quarterly cash report on record, so no quarterly cash balance or funding-runway figure is disclosed, and there are no proposed securities issues (Appendix 3B) pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
4.6%
Max option dilution
0.0%
ITM option dilution
3
Raises · last 12 months
—
Cash cover · not a quarterly filer

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 325.5M per Appendix 2A (16 Dec 2025).
249.6M277.9M306.2MDec 24Sept 25July 26Cash raise · 3 Dec 2025Cash raise · 5 Nov 2025Cash raise · 16 Oct 2025Cash raise · 17 July 2025Cash raise · 16 July 2025Cash raise · 15 July 2025Cash raise · 2 June 2025Cash raise · 28 May 2025Cash raise · 14 Jan 2025Cash raise · 7 Jan 2025

Cash runway

Not a quarterly cash filer. This company does not lodge Appendix 4C/5B quarterly cash reports, so cash runway does not apply.

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
29 June 20263H · cancellationIMC : ORDINARY FULLY PAID322.8MAppendix 3H
17 June 20263H · cancellationIMC : ORDINARY FULLY PAID326.7MAppendix 3H
11 Mar 20263H · cancellationIMC : ORDINARY FULLY PAID326.7MAppendix 3H
16 Dec 20252A · quoted issueIMC : ORDINARY FULLY PAID325.5MAppendix 2A
15 Dec 20252A · quoted issueIMC : ORDINARY FULLY PAID326.3MAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

10 cash raises in the last 24 months · 3 in the last 12 months

$3.6M
Capital raise
3 Dec 2025
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

4.6%
Total overhang · of current shares
0.0%
In the money · at current price
14.9M
Potential new shares
—
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
18 Nov 2025Ravi SavarirayanOther—1.0M—3Y notice
18 Nov 2025Dr Jeannette JoughinOther—1.0M—3Y notice
18 Nov 2025Daniel PollockOther818k2.0M—3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

26 July 2026Investor Presentation
20 July 2026TechKnow Invest Roadshow Presentation
19 July 2026Investor Presentation
16 July 2026$PImmuron FY26 Sales Update
15 July 2026Change in substantial holding
5 July 2026IMM-529 CDI Partnering Update
30 June 2026Change in substantial holding
29 June 2026Notification of cessation of securities - IMC
22 June 2026Unmarketable Parcel Facility Update
17 June 2026Notification of cessation of securities - IMC
2 June 2026Change in substantial holding
28 May 2026$PResponse to ASX Price Query
7 May 2026Emerging Growth Conference
29 Apr 2026Emerging Growth Conference
16 Apr 2026$PImmuron Double Digit 3Q Sales Growth
12 Apr 2026Small Holding Share Sale Facility
11 Mar 2026Notification of cessation of securities - IMC
4 Mar 2026Presentation to Coffee Microcaps Conference
26 Feb 2026Change in substantial holding
25 Feb 2026$PStrategic Update and HY26 Results

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.